
Actuality Systems to Demonstrate its Perspecta Spatial 3D
Platform at SID 2002 in Boston
Unique Display Technology Brings 360-Degree Viewing to Biotechnology,
Drug Design, Security, and Medical Imaging
BURLINGTON, Mass. -- May 8, 2002 -- Actuality Systems, Inc.,
a pioneer in the development of spatial 3D visualization technology,
will demonstrate its Perspecta platform at SID 2002, the 33rd
Annual Symposium of the Society for Information Display, May 21-23,
at the Hynes Convention Center in Boston. Previously known by
its code name, Helios, the Perspecta platform consists of two
elements: the Perspecta spatial display, which projects 3D imagery
inside a 20-in transparent dome, and the Perspecta OS.
The Perspecta spatial 3D platform is compatible with several
molecular visualization software packages and enables users to
render high-resolution spatial images that can be viewed aross
a full 360 degrees. The Perspecta SDK, based on an open standard,
enables application development and migration.
"It's been barely a year since we first announced our prototype
display," said Actuality's founder and CTO, Gregg Favalora.
"We've come a long way since then. Today, we have better
performance, higher image quality, and developer support. But
the biggest change is that we are now actively selling our Perspecta
platform."
In April, Actuality named Cameron Lewis, formerly of Netscape,
McAfee.com, and MedicaLogic, as CEO. Since then, Lewis has worked
to focus the company on bringing Perspecta to market. In the months
ahead, the company plans to extend its software development kit,
provide tools for industry-leading 3D applications, and accomplish
its goal of providing unique visualization research tools to proteomics
and drug discovery companies.
"3D images in 2D displays are widely used in a number of
fields," said Lewis. "Perspecta makes it possible to
visualize 3D in 3D, in real time, in high resolution, and with
existing applications. For example, Perspecta can be used for
lead optimization during the drug development process, allowing
chemists to rapidly cycle through thousands of pharmaceutical
candidates. And we enable high-performance visualization in other
industries by offering a suite of development tools, available
soon from our website in the Perspecta SDK."
The Perspecta display illuminates a world-record 100 million
volume pixels, or "voxels," throughout a full range
of 3D locations within a transparent sphere. This is unlike 3D
displays that require special stereoscopic goggles to simulate
multi-dimensional imagery, or flat-screen monitors that render
3D data into flat 2D images. In addition, a custom embedded graphics
architecture allows fully animated 3D imagery to be controlled
and maneuvered from the customer's computer. The Perspecta OS
includes the company's Spatial Rendering Kernel, a collection
of proprietary algorithms which slice the user's 3D data into
a format suitable for projection into spatial 3D.
Typical applications for the platform include: drug discovery,
such as visualization of protein structures; surgical planning
and radiation treatment planning, for doctors working to understand
the exact location of a tumor on an x-ray or mammogram; air-traffic
control; game development; security specialists seeking a faster
and more reliable way to visualize the contents of freight or
passenger luggage; and numerous other possibilities.
The Perspecta spatial 3D platform is priced from $40,000 per
station including the Perspecta OS and a Perspecta display. The
Perspecta SDK is available free. More information is available
at www.actuality-systems.com
or at the SID conference, booth number 3428.
# # #
ABOUT ACTUALITY SYSTEMS
Actuality Systems, Inc. develops, produces, sells, and licenses
the Perspecta spatial 3D platform, a combination of hardware and
software that permits 360-degree visualization, simulation, and
collaboration. Founded in 1997 in Cambridge, the firm has received
venture funding and now operates from offices in Burlington, Mass.,
north of Boston. Actuality's President and CEO is Cameron Lewis,
who, in addition to executive roles at Netscape and PatientKeeper,
developed the first anti-virus ASP service at McAfee.com, and
headed up more than $400 million in mergers and acquisitions at
MedicaLogic. The company's chief technology officer, Gregg Favalora,
has been named one of the top young technologists by MIT Technology
Review. Company chairman, Rob Ryan, was a founder and former CEO
of Ascend Communications, Inc., which was acquired by Lucent in
a deal valued at more than $24 billion.
Media Contact Info:
Ellen Walravens, aMate Comm., (781) 281-1546; Ellen@amatecommunications.com
|